Abstract:Abstract Background and aims Chronically elevated levels of circulating lipoprotein-amyloid-beta (Abeta) are implicated in the disruption of the blood-brain barrier and the initiation of a neurodegenerative cascade leading to Alzheimers disease (AD). Type 2 diabetes is associated with BBB dysfunction, dyslipidaemia, and an increased risk of AD. However, alterations in triglyceride-rich lipoproteins (TRL)-Abeta homeostasis and its downstream effects on the BBB in a diabetes context remain explored. This study aimed to 1) investigate, in a preclinical model of diabetes, the hypothesis that diabetes-induced impairments in TRL-Abeta metabolism might compromise BBB integrity and exacerbate cognitive function and behavioural changes, and 2) assess the efficacy of interventions that improve TRL catabolism, including probucol, HA1, and ApoC3 siRNA, to prevent disease progression by lowering circulating TRL-Abeta levels. Methods Five-week-old db/db mice underwent a 9- or 23-weeks dietary interventions with probucol, a probucol prodrug HA1, or a standard diet with four-weekly injections of ApoC3 siRNA. Db/+ mice served as negative controls for each treatment duration. Blood levels of Abeta and ApoB were measured using ELISA. Immunofluorescence imaging was used to quantify enterocytic levels of Abeta and ApoB, and assess changes in neurovascular integrity (IgG, PDGFRbeta, ZO1, occludin), neuroinflammation (GFAP, Iba1), and cerebral oxidative stress (8OHdG). Results Our results indicate that diabetes increased the abundance of plasma amyloid, specifically Abeta42, which correlated with enterocytic abundance, suggesting exaggerated postprandial excretion. Disrupted plasma amyloid homeostasis was associated with BBB breakdown, including diminished barrier function, and the loss of pericytes and astrocytes. Provision of the probucol analogue, HA1, normalised plasma and enterocytic amyloidemia concomitant with the preservation of the neurovascular junction. Treatment with ApoC3 siRNA attenuated plasma Abeta42 and modestly reduced neurovascular inflammation. Conclusion The findings further support the hypothesis that aberrant peripheral metabolism of lipoprotein-Abeta is associated with microvascular corruption and the development of anxiety-like behaviour. HA1 is more effective than probucol or ApoC3 siRNA in positively modulating lipoprotein-amyloid homeostasis in db/db mice and maintaining central capillary integrity.

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on two aspects: 1. **Explore the impact of diabetes on lipoprotein - amyloid protein metabolism and its influence on the integrity of the blood - brain barrier (BBB) and cognitive function**: - The research hypothesis is that the metabolic disorder of lipoprotein - amyloid protein (TRL - Aβ) caused by diabetes may damage the integrity of the blood - brain barrier and exacerbate cognitive function and behavioral changes. - Specifically, the research focuses on how the abnormal metabolism of lipoprotein - amyloid protein leads to the destruction of the blood - brain barrier in the context of diabetes, and how this destruction further triggers neuroinflammation and cognitive function decline. 2. **Evaluate the effectiveness of intervention measures**: - Evaluate the effects of several intervention measures (including probucol, probucol analogue HA1 and ApoC3 siRNA) in improving lipoprotein - amyloid protein metabolism, protecting the integrity of the blood - brain barrier and preventing neuroinflammation and cognitive function decline. - In particular, the research aims to verify whether these intervention measures can prevent disease progression by reducing the level of TRL - Aβ in the circulation. ### Main research background - **The relationship between Alzheimer's disease (AD) and diabetes**: Increasing evidence shows that type 2 diabetes (T2D) is an important risk factor for Alzheimer's disease. Diabetes is associated with brain atrophy, blood - brain barrier dysfunction and amyloid deposition, which may be markers of AD pathology. - **Lipoprotein - amyloid protein metabolism**: Recent studies have shown that the abnormal peripheral metabolism of lipoprotein - amyloid protein (especially triglyceride - rich lipoprotein - amyloid protein, TRL - Aβ) may play a key role in the neurovascular pathology of AD. - **Model selection**: In order to more accurately simulate the connection between diabetes and AD, the study selected db/db mice lacking leptin receptors as models. These mice can better replicate insulin - resistant - induced diabetes without being interfered by a high - fat diet. ### Research methods - **Animal model**: Use 5 - week - old db/db mice and db/+ mice for experiments, and divide them into a standard diet group and three intervention groups (probucol, HA1, ApoC3 siRNA). - **Behavioral test**: Evaluate anxiety - like behavior through the open - field test, and evaluate cognitive function through the new object recognition (NOR) test and the passive avoidance test. - **Sample collection and analysis**: Collect blood samples to detect blood glucose, insulin, cholesterol, triglyceride and total ApoB levels. Detect the expression of Aβ and ApoB in intestinal cells and brain tissues by immunofluorescence microscopy, evaluate the integrity of the blood - brain barrier, the expression of tight junction proteins and pericytes, as well as the levels of neuroinflammation and oxidative stress. ### Conclusions - **Main findings**: - Diabetes increases the amyloid protein level in plasma, especially Aβ42, which is associated with the increase in the amyloid protein level in intestinal cells, suggesting an increase in postprandial secretion. - The disorder of plasma amyloid protein metabolism is related to blood - brain barrier dysfunction, including weakened barrier function, loss of pericytes and astrocytes. - The probucol analogue HA1 can effectively reduce the amyloid protein level in plasma and intestinal cells, protect the neurovascular connection, and reduce oxidative stress and anxiety. - ApoC3 siRNA can reduce the Aβ42 level in plasma and moderately reduce neurovascular inflammation. - **Significance**: - These findings support the association between abnormal peripheral lipoprotein - amyloid protein metabolism and microvascular injury and the development of anxiety - like behavior. - HA1 is more effective than probucol or ApoC3 siRNA in regulating lipoprotein - amyloid protein metabolism and maintaining the integrity of central capillaries.

Effects of HA1 (a Probucol Analogue) and ApoC3 siRNA on Lipoprotein-Amyloid Metabolism, Neurovascular Integrity and Cognitive Function in db/db Mice

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice

Probucol prevents blood-brain barrier dysfunction in wild-type mice induced by saturated fat or cholesterol feeding

Alleviative Effect of Alpha-Lipoic Acid on Cognitive Impairment in High-Fat Diet and Streptozotocin-Induced Type 2 Diabetic Rats

BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease

DHA dietary intervention caused different hippocampal lipid and protein profile in ApoE-/- and C57BL/6J mice

Altering plasma lipids and liver enzyme activities via hippocampal injections of hen Lysozyme amyloid aggregates in an Alzheimer's disease mouse model: Insights into the therapeutic role of Bis (Indolyl) phenylmethane

Gut microbiota modulation in Alzheimer's disease: Focus on lipid metabolism

Dicer1 promotes Aβ clearance via blocking B2 RNA-mediated repression of apolipoprotein E

Peripheral metabolism of lipoprotein-amyloid beta as a risk factor for Alzheimer's disease: potential interactive effects of APOE genotype with dietary fats

Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology

Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice

Effects of a High-Fat Diet on Insulin-Related miRNAs in Plasma and Brain Tissue in APPSwe/PS1dE9 and Wild-Type C57BL/6J Mice

Modulation of oxidative stress and apoptosis by alteration of bioactive lipids in the pancreas, and effect of zinc chelation in a rat model of Alzheimer's disease

Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer's disease in a APP/PS1 transgenic mouse model

Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's disease

Analysis of early effects of human APOE isoforms on Alzheimer's disease and type III hyperlipoproteinemia pathways using knock-in rat models with humanized APP and APOE

Resveratrol Attenuates the Disruption of Lipid Metabolism Observed in APP/PS1 Mouse Brains and Cultured Primary Neurons Exposed to Aβ

Biochemical Investigation of the Association of Apolipoprotein E Gene Allele Variations with Insulin Resistance and Amyloid-β Aggregation in Cardiovascular Disease.

Effects of human apolipoprotein E isoforms on the amyloid β‐protein concentration and lipid composition in brain low‐density membrane domains